Wave Life Sciences Ltd. Stock

$14.89

4.34% yesterday

Nasdaq, Nov 25, 10:16 pm CET

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Wave Life Sciences Ltd. Stock price

$14.89

-16.77 52.97% 5Y

Nasdaq, Closing price Mon, Nov 25 2024

+0.62 4.34%

ISIN

SG9999014716

Symbol

WVE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$2.27b
Enterprise Value	$2.00b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	37.22
P/S ratio (TTM) P/S ratio	42.36
P/B ratio (TTM) P/B ratio	15.60
Revenue growth (TTM) Revenue growth	-37.29%
Revenue (TTM) Revenue	$53.61m
EBIT (operating result TTM) EBIT	$-152.05m
Free Cash Flow (TTM) Free Cash Flow	$-143.07m
Cash position	$310.95m
EPS (TTM) EPS	$-1.11
P/E forward	negative
P/S forward	42.84
EV/Sales forward	37.64
Short interest	7.74%

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Get Started for Free Today

Wave Life Sciences Ltd. Stock Analysis

Unlock Scores for Free

??

10 Analysts have issued a Wave Life Sciences Ltd. forecast:

9x Buy

90%

More details on Analyst Estimates Including Price Targets

10 Analysts have issued a Wave Life Sciences Ltd. forecast:

Buy

90%

Hold

10%

Analyst Estimates with Stock Price Targets

Financial data from Wave Life Sciences Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	54 54	37% 37% 100%
- Direct Costs	8.69 8.69	9% 9% 16%
Gross Profit	45 45	41% 41% 84%
- Selling and Administrative Expenses	39 39	21% 21% 73%
- Research and Development Expense	149 149	17% 17% 278%
EBITDA	-143 -143	72% 72% -267%
- Depreciation and Amortization	8.69 8.69	9% 9% 16%
EBIT (Operating Income) EBIT	-152 -152	64% 64% -284%
Net Profit	-143 -143	67% 67% -266%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Wave Life Sciences Ltd. Stock News

Neutral

GlobeNewsWire

●

11 days ago

Wave Life Sciences to Present at Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Jefferies London Healthcare Confer...

Neutral

Seeking Alpha

●

14 days ago

Wave Life Sciences Ltd. (WVE) Q3 2024 Earnings Call Transcript

Wave Life Sciences Ltd. (NASDAQ:WVE ) Q3 2024 Results Conference Call November 12, 2024 8:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno - President & Chief Executive Officer Anne-Marie Li-Kwai-Cheung - Chief Development Officer Kyle Moran - Chief Financial Officer Conference Call Participants Steven Seedhouse - Raymond James Joon L...

Neutral

GlobeNewsWire

●

27 days ago

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

WVE-007 (INHBE GalNAc-siRNA for obesity) is on track to initiate a clinical trial in 1Q 2025; new preclinical data for WVE-007 demonstrate opportunities for monotherapy, for synergistic use with GLP-1s, and for maintenance to avoid rebound weight gain following cessation of GLP-1s

More Wave Life Sciences Ltd. News

Company Profile

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, development, and commercialization of nucleic acid-based therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Head office	Singapore
CEO	Paul Bolno
Employees	268
Founded	2012
Website	www.wavelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now